Blood Clot News and Research

RSS

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.

FDA to highlight benefits and risks of hormone therapy for menopausal symptoms

The Food and Drug Administration (FDA) is implementing a nationwide information campaign to raise awareness about the resources available to address questions related to the benefits and risks of hormone therapy for menopausal symptoms.

29 Sep 2004

Studies confirm that chronic kidney disease independently increases the risk of developing cardiovascular disease

A pair of new epidemiology studies confirms that chronic kidney disease independently increases the risk of developing cardiovascular disease, even among people with early kidney disease and after considering other risk factors such as diabetes, hypertension and high cholesterol.

29 Sep 2004

Guidant announces plans to initiate vulnerable plaque study

Guidant has announced plans to conduct a study designed to increase clinical understanding of “vulnerable” plaques – lipid-rich coronary lesions that suddenly rupture – that may cause most heart attacks.

27 Sep 2004

Small proportion of women eligible for discussions about use of tamoxifen to prevent cancer

A survey conducted in primary care practices showed that a small proportion of women are eligible for discussions about use of tamoxifen to prevent cancer, and of those women, the proportion of breast cancers that would be prevented is also small

26 Sep 2004

Steps to minimise the risk of onward transmission of vCJD

Selected groups of patients are this week being notified about the results of a risk assessment exercise for blood plasma products.

22 Sep 2004

BMA Cymru Wales to launch no smoking campaign

BMA Cymru Wales will tomorrow be launching its 'Let the Dragon Breathe' poster campaign at the National Assembly for Wales after a meeting of the Assembly's committee on smoking in public places.

22 Sep 2004

New culprit behind the brain injury suffered by stroke victims

Researchers have uncovered a new culprit behind the brain injury suffered by stroke victims. Their new study, published in the Sept. 17 issue of Cell, links brain cell damage to a rise in brain acidity following the oxygen depletion, or ischemia, characteristic of stroke.

18 Sep 2004

Coronary angioplasty within 24 hours of medical therapy could improve the outcome for heart-attack patients

Results of a randomised trial in this week’s issue of THE LANCET suggest that a more aggressive approach involving coronary angioplasty soon after anticlotting medical therapy is safe and could offer a better prognosis than more conservative treatment for patients who have had heart attack.

17 Sep 2004

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

14 Sep 2004

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

New antithrombotic guidelines from the American College of Chest Physicians (ACCP) introduce novel therapies for the prevention and treatment of thrombosis and, for the first time, offer specific recommendations for long-distance travelers.

14 Sep 2004

Patients who experience medical or neurological complications following stroke are at a greater risk of dying in the hospital

Patients who experience medical or neurological complications following stroke, such as pneumonia or brain swelling, are at a greater risk of dying in the hospital, according to an article in the September 13 issue of The Archives Internal Medicine, one of the JAMA/Archives journals.

12 Sep 2004

Grant to study genetics and drug interaction

A University of Minnesota researcher received a nearly $1 million grant from the National Institutes of Health (NIH) to study how genetic differences affect whether people will experience dangerous drug interactions and how to adjust medications to avoid those interactions.

10 Sep 2004

Herbals, surgery and anesthesia don't always mix

The woman who swears by gingko biloba wonders why her mouth won't stop bleeding after wisdom tooth surgery. What she doesn't know is that the herbal remedy she takes religiously to enhance mental alertness also acts as a powerful blood thinner that inhibits clotting.

10 Sep 2004

Genetically modified fish may help treat hemophiliacs

A human blood-clotting factor used to treat some people with haemophilia and accident victims suffering serious bleeding has been produced using genetically modified fish.

9 Sep 2004

Long-term outcomes for liver transplantation due to hepatitis C

A new study on liver transplants necessitated by the hepatitis C virus (the most common indication for this type of transplant) found that long-term outcomes are similar to patients receiving transplants due to other diseases.

8 Sep 2004

Pig tissue may help reduce the damage and disability of stroke

A tiny capsule containing tissue that secretes a cocktail of brain-nourishing neurotrophic factors may one day help reduce the damage and disability of stroke, according to research published in the September issue of Stroke.

7 Sep 2004

Mitochondrial genes cause nuclear mischief

While the nucleus of a cell may be its command headquarters, mitochondria are equally vital—they are the power plants of the cell, and without them all cellular activity would quickly and irrevocably come to a halt.

7 Sep 2004

Bone marrow produces cells that permanently heal wounds

Bone marrow produces cells that not only help fight infection but also permanently heal wounds, according to research at the University of Washington. Previously, researchers had not known that bone marrow contributed to the development of new skin in wounds.

5 Sep 2004

Benefit of using clot-busting drug tissue plasminogen activator (tPA) for ischemic stroke

An independent review of data from a landmark clinical trial has validated the benefit of using the clot-busting drug tissue plasminogen activator (tPA) for ischemic stroke, when given within three hours of symptom onset under a strict treatment protocol.

2 Sep 2004

The Australian Government response to Senate inquiry into hepatitis C and blood supply

Although the Inquiry found that decision makers had made reasonable decisions in the 80s, based on the evidence available, medically acquired hepatitis C has hurt many people.

30 Aug 2004